FDA Cybersecurity Compliance
Cybersecurity is no longer a secondary review topic. It has become a core regulatory expectation for medical device and digital health manufacturers.
Recent cybersecurity guidance from the U.S. Food and Drug Administration has significantly expanded the role of cybersecurity within premarket submissions and lifecycle governance. Manufacturers are now expected to demonstrate that cybersecurity risks have been systematically addressed throughout the product development lifecycle.
Regulators increasingly expect manufacturers to show evidence of a Secure Product Development Framework (SPDF) integrated into their quality and software development processes. This includes structured threat modeling, software bill of materials (SBOM) transparency, vulnerability management planning, and defined processes for post-market monitoring and response.
Cybersecurity is no longer evaluated as a standalone technical feature. It is assessed as part of the overall development lifecycle and risk management framework supporting the device.
Where Cybersecurity Now Applies
These expectations affect a wide range of development and regulatory scenarios, including:
• New 510(k), De Novo, and PMA submissions
• Software updates and significant modifications to cleared devices
• Connected medical devices and digital health platforms
• AI-enabled systems and cloud-based medical software
• Previously cleared products undergoing lifecycle or architecture changes
In many cases, cybersecurity documentation now becomes a determining factor in whether a submission proceeds smoothly through regulatory review.
Cybersecurity as a Regulatory Control
For modern medical devices, cybersecurity is not simply an information technology concern. It is a product safety and regulatory compliance discipline that intersects with risk management, software lifecycle controls, and post-market surveillance.
Manufacturers must be able to demonstrate that cybersecurity considerations are integrated into the development process itself rather than applied as a late-stage technical review.
How Frelong Health Supports Cybersecurity Compliance
Frelong Health helps organizations translate evolving cybersecurity expectations into practical development and documentation strategies that support regulatory submissions.
Our work focuses on helping teams:
• Align development practices with cybersecurity expectations embedded in regulatory review
• Establish structured threat modeling and security risk analysis activities
• Develop SBOM transparency and component tracking strategies
• Define vulnerability monitoring and coordinated disclosure processes
• Integrate cybersecurity considerations into software lifecycle documentation
The objective is to ensure that cybersecurity controls are not only technically sound but also clearly documented and defensible during regulatory review.
Result
Organizations are better positioned to demonstrate that cybersecurity risks have been systematically addressed throughout the product lifecycle, reducing submission friction and strengthening long-term product governance.
Frequently Asked Questions
Common questions about FDA cybersecurity expectations, Secure Product Development Frameworks (SPDF), SBOM requirements, and lifecycle risk management for regulated digital health.
-
The FDA expects manufacturers to demonstrate that cybersecurity risks are systematically addressed throughout the product lifecycle. This includes threat modeling, risk management integration, SBOM transparency, and post-market vulnerability monitoring.
-
A Secure Product Development Framework (SPDF) is a structured approach to integrating cybersecurity into the development lifecycle. It includes threat modeling, secure design practices, verification activities, and ongoing monitoring of vulnerabilities after release.
-
A Software Bill of Materials (SBOM) is a detailed list of software components used within a product. Regulators require SBOMs to improve transparency, support vulnerability management, and ensure risks from third-party components are understood and controlled.
-
Cybersecurity documentation is now a key component of 510(k) submissions. Incomplete threat modeling, missing SBOMs, or weak vulnerability management processes can delay or block regulatory review.
-
Cybersecurity risks must be incorporated into the overall risk management framework, typically aligned with ISO 14971. This ensures that threats, vulnerabilities, and potential harms are identified, controlled, and verified throughout the lifecycle.
-
Common gaps include lack of structured threat modeling, incomplete SBOM documentation, weak vulnerability monitoring plans, and poor integration of cybersecurity into lifecycle and risk management processes.
Common Questions by Service
How do I build an ISO 13485-compliant QMS for digital health?
Structured QMS systems must align documentation, risk management, and lifecycle controls from the start.
Explore QMS Systems
What should be included in a Design History File (DHF)?
A defensible DHF connects requirements, risk controls, and verification evidence into a traceable system.
View DHF Review Services
How should software be developed in a regulated digital health environment?
Software must be developed within a controlled lifecycle aligned to IEC 62304, with structured requirements, traceability, risk integration, and verification activities.
Explore Software Development
What does a risk-based verification and validation strategy look like?
Testing must align to risk, ensuring hazards are controlled and verification evidence is defensible.
Explore V&V Advisory
How should CAPA investigations be structured in a regulated QMS?
CAPA investigations must demonstrate clear root cause analysis, risk evaluation, and defensible corrective actions aligned to regulatory expectations.
Explore CAPA Engine
How do I prepare my QMS for an MDSAP audit?
MDSAP readiness requires aligned procedures, audit-ready documentation, and clear traceability across quality system processes.
Explore MDSAP Readiness
A strong 510(k) requires structured documentation, clear substantial equivalence, and defensible verification and validation evidence.
View 510(k) Strategy & Submission
Make it secure, compliantly.
-
Evaluate It.
Under current FDA Premarket Submission Cybersecurity guidance, sponsors must demonstrate structured cybersecurity risk management, secure product development processes, threat modeling, SBOM transparency, vulnerability monitoring, and post-market response planning.
This is not optional.
And it is not limited to new devices.
Previously cleared products are increasingly being re-evaluated against modern cybersecurity expectations, especially where software updates, connectivity changes, or AI components are introduced.
Our Cybersecurity Compliance Gap Analysis Toolkit provides a structured framework to assess your current posture against FDA expectations and international standards.
You gain clarity on where you stand before regulators do.
Start a Cybersecurity Gap Analysis
-
Strengthen It.
Our toolkit evaluates:
• Secure Product Development Framework (SPDF) alignment
• Threat modeling and risk documentation
• SBOM completeness and transparency
• Vulnerability monitoring processes
• Patch and update governance
• Secure configuration management
• Post-market cybersecurity response planning
We provide a written gap assessment with prioritized remediation guidance — tailored to both new submissions and legacy products requiring re-review.
This transforms cybersecurity from a documentation burden into a defensible engineering discipline.
-
Defend It.
For teams requiring deeper support, we offer hands-on cybersecurity review and remediation.
We work directly with engineering and quality teams to:
• Rebuild cybersecurity risk documentation
• Strengthen threat modeling frameworks
• Align technical controls with regulatory expectations
• Integrate cybersecurity into design controls and change management
• Prepare documentation for FDA reviewWhether preparing for a new 510(k), De Novo, or PMA submission or proactively strengthening previously cleared software we help you establish structured, defensible cybersecurity governance.
Cybersecurity is now a regulatory expectation.
We help you meet it with confidence.